Paulin Nkusi KYBORA is proud to be working with Foundation Rwanda on a program that empowers second-generation rape survivors of the Rwandan genocide Meet Paulin, a second-generation survivor and entrepreneur from Rwanda. Paulin’s childhood in Rwanda fueled his passion for technology, inspiring him to pursue his entrepreneurial dreams and make a meaningful impact in his […]
A look at the factors driving growth and future potential in Latin America’s largest market In recent years, the pharmaceutical sector in Latin America has experienced significant growth. This has been driven by 1) an increase in average life expectancy resulting in an expanding elderly cohort, which has additional healthcare needs, 2) an increase in […]
Um olhar sobre os fatores que impulsionam o crescimento e futuro potencial do maior mercado da América Latina Nos últimos anos tem sido possível observar um crescimento significativo no setor farmacêutico no Brasil. Isto tem sido impulsionado por 1) um aumento populacional e da esperança média de vida, o quetem vindo a criar uma população […]
KYBORA releases a Chinese version of its website – KYBORA has collaborated with some of the best biotech and pharma companies in China for several years now and has fostered lasting relationships with them. These collaborations have enriched KYBORA’s expertise in the region and have highlighted the immense potential for growth and innovation inherent to […]
Biopharma investment strategies shift due to IRA – On the last day of BIO’s 2023 Investor Forum, the discussion focused on the Inflation Reduction Act and its impact on biopharma investment decisions, which will now require companies to reevaluate their existing strategies to cover potential scenarios because of the IRA in the next 18 to […]
Emilienne Kambibi KYBORA is proud to be working with Foundation Rwanda and its incredible team members on a program that empowers second-generation rape survivors of the Rwandan genocide. Emilienne Kambibi, Senior Counselor for Foundation Rwanda, is an advocate for mental health among survivors of the 1994 Genocide against the Tutsi. A survivor herself, she has […]
Reach Out for Our Complimentary Global Biotech Licensing Readiness Assessment In our complimentary one-hour consultation, our team of seasoned professionals will engage in a Q&A session with you. This complimentary offering is designed to provide you with invaluable insights into the international licensing prospects of your product. We will explore your strategic objectives, the strengths […]
Developing groundbreaking therapies, commercializing products, and/or finding the right partners are all essential activities for successful biotech companies. These tasks can be challenging and hiring an experienced consultant is often the best course of action. Following are the 8 strategic consulting services KYBORA is most often asked to perform. Click here to download the document.
Sept. 27, 2023 – The Impact of the Inflation Reduction Act (IRA) on Orphan Drugs – ORPHAN Cures Act introduced to boost new rare disease drug development (https://bio.news/health/orphan-cures-act-introduced-to-boost-new-rare-diseasedrug-development/) | The ORPHAN Cures Act, introduced by lawmakers on Sept. 18, 2023, aims to promote the development of new drugs for rare diseases. This legislation responds to […]
The biotech industry is characterized by intense competition stemming from scientific breakthroughs, innovative therapies, and cutting-edge technologies. Biotech CEOs encounter various challenges when addressing this competitive environment while positioning their companies for success.Click here to download the document.
